R
RANI
Rani Therapeutics Holdings, Inc.
0.6093
-0.0079-1.28%After Hours: 0.6100 +0.0007 +0.11%17:18 10/27 EDT
OPEN/PREV CLOSE0.6226/0.6172
TODAY RANGE0.6000-0.6296
VOL327.77K
MARKET CAP84.93M
52 WEEK RANGE0.5737-2.630
AVG VOL (3M)591.30K
% TURNOVER0.23%
TURNOVER--
P/E (TTM)-2.3019
% RANGE4.80%
EPS(TTM)-0.2647
P/E(FORWARD)-3.5153
P/B2.119
BVPS0.2875
DIVIDEND--
P/S45.47
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP66.88M
SHARES OUTSTANDING139.40M
NEXT EARNINGS11/06-11/12
FREE FLOAT109.77M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·5d ago
Rani Therapeutics Is Maintained at Buy by Chardan Capital
Benzinga·10/15 10:06
Why Ericsson Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
TipRanks·10/06 10:36
H.C. Wainwright Sticks to Their Buy Rating for Rani Therapeutics Holdings (RANI)
TipRanks·10/05 12:28
Rani reports RaniPill acceptance into FDA Emerging Technology Program
Benzinga·10/05 12:09
Rani Therapeutics Joins FDA Emerging Technology Platform
TipRanks·09/21 17:56
H.C. Wainwright Sticks to Their Buy Rating for Rani Therapeutics Holdings (RANI)
Dow Jones·08/21 10:42
Rani Therapeutics Price Target Maintained With a $11.00/Share by HC Wainwright & Co.
Benzinga·08/18 12:45
This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Dow Jones·08/18 12:04
Rani Therapeutics Initiated at Buy by Chardan Capital
Dow Jones·08/18 12:04
Rani Therapeutics Price Target Announced at $6.00/Share by Chardan Capital
Same Industry
Name/Symbol
Change%
Price